Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Namenda XR Generics Coming Soon? US Court Rulings Clear Path For Multiple Launches

Jan 30 2018

• By Sue Sutter

Gavel_1200x675

Related Content

Allergan Relying On 'Six Stars' And Other R&D Programs To Blunt Restasis Blow

Jan 19 2018

Amneal Loses Bid For 180-Day Generic Exclusivity On Namenda XR

Jan 30 2018

Related Companies

Allergan plc

Amneal Pharmaceuticals, Inc.

Par Pharmaceutical Companies Inc.

Sun Pharmaceutical Industries Ltd.

Lupin Limited

Viatris Inc.

Apotex Inc.

Forest Laboratories, Inc.

Teva Pharmaceutical Industries Ltd.

Par Pharmaceutical Companies Inc.

Additional Topics

United States Generic Drugs Legal Issues Intellectual Property BioPharmaceutical Neurology

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window